Third agents for type 2 diabetes are similar in efficacy

NEW YORK (Reuters Health) - For patients with type 2 diabetes not controlled with metformin and a sulfonylurea, the choice of an additional agent should be based on individual clinical characteristics since improvements in glucose control are similar.

© 2023 MJH Life Sciences

All rights reserved.